Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
SERA
STRONG SELLSera Prognostics, Inc. · Healthcare · United States · $80M · Avg Vol: $79K/d
5
StockRankGet insider-trade alerts
Q
20
V
31
M
23
P/E (TTM)
—
ROE
-39.6%
D/E
0.0x
Dividend %
—
Loading 1Y...
PRICE (1Y)+9.6%
SMA 50SMA 200
Close
$2.05
RSI (14)
51.6
52W High
$3.95
From 52W High
0.5%
SCORE BREAKDOWN
Quality
20
ROIC
-41.3%18.5
ROE
-39.6%22.1
GP/Assets
-0.1%9.6
Op. Margin
-66857.1%0.8
FCF/Assets
-27.1%13.1
Piotroski
111.4
Int. Cover
-50.0x6.3
D/E Ratio
0.04x73.8
Current Ratio
2.12x39.9
Value
31
P/E (TTM)
—N/A
EV/EBITDA
-1.0x25.0
P/FCF
—N/A
P/B
1.2x79.2
P/S
1408.3x2.5
Div Yield
—N/A
Momentum
23
52W High %
52%28.0
RS 6M
-45%17.8
SMA 50/200
0.78x17.1
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+10%27.7
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$80M
P/E (Forward)
-3.6x
Gross Margin
—
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of SERA are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| SERA | Sera Prognostics, Inc.(you) | $80M | 5 | STRONG SELL |
| LDX.AX | Lumos Diagnostics Holdings Limited | $75M | 3 | STRONG SELL |
| RPID | Rapid Micro Biosystems, Inc. | $99M | 4 | STRONG SELL |
| LNSR | LENSAR, Inc. | $69M | 11 | STRONG SELL |
| EBR.AX | EBR Systems, Inc. | $115M | 2 | STRONG SELL |
| HYPR | Hyperfine, Inc. | $95M | 13 | STRONG SELL |
| OM | Outset Medical, Inc. | $75M | 16 | STRONG SELL |
| CVRX | CVRx, Inc. | $126M | 12 | STRONG SELL |
| LUCD | Lucid Diagnostics Inc. | $173M | 7 | STRONG SELL |
| COCH | Envoy Medical, Inc. | $51M | 14 | STRONG SELL |
Peer medians: ROE -25.5% · P/E 27.6x · Gross margin 50.5%